Hagan Joseph P
Insider CIK 1465278 · OREX Sr. VP, Corporate Development · RGLS President and CEO, Director · ZSAN Director · AUPH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 2,976 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 1,350,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 990,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 249,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 1,312,500 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 6,500 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 1,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 100,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 90,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 160,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 100,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer | 2025-06-25 | 2025-06-27 | 571,558 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2025-01-30 | 2025-01-31 | 1,350,000 | — | $0 | 1,350,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2025-01-30 | 2025-01-31 | 50,000 | $1.09 | $54.5K | 260,808 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2025-01-14 | 2025-01-15 | 11,764 | $1.26 | $14.8K | 210,808 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2025-01-13 | 2025-01-15 | 115,290 | $1.26 | $145.3K | 222,572 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2025-01-09 | 2025-01-10 | 62,000 | $1.30 | $80.6K | 337,862 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2025-01-09 | 2025-01-10 | 218,750 | $1.36 | $297.5K | 275,862 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2024-05-20 | 2024-05-21 | 990,000 | — | $0 | 990,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2024-01-18 | 2024-01-18 | 14,580 | $1.19 | $17.4K | 57,112 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2024-01-12 | 2024-01-17 | 249,000 | — | $0 | 249,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2024-01-12 | 2024-01-17 | 30,000 | — | $0 | 71,692 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2023-08-10 | 2023-08-14 | 1,312,500 | — | $0 | 1,312,500 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2023-05-19 | 2023-05-23 | 272 | $10.58 | $2.9K | 11,961 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | M Exercise deriv | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 0 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | M Exercise | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 12,233 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2023-01-11 | 2023-01-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2022-05-18 | 2022-05-20 | 8,733 | — | $0 | 8,733 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2022-05-18 | 2022-05-20 | 14,612 | — | $0 | 14,612 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2022-05-10 | 2022-05-11 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2022-01-26 | 2022-01-26 | 100,000 | $0.22 | $22.0K | 417,006 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2022-01-12 | 2022-01-26 | 1,600,000 | — | $0 | 1,600,000 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | M Exercise deriv | 2022-01-03 | 2022-01-04 | 40,000 | — | $0 | 10,000 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2022-01-03 | 2022-01-04 | 634 | $23.29 | $14.8K | 3,500 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2022-01-03 | 2022-01-04 | 39,366 | $22.58 | $888.9K | 4,134 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | M Exercise | 2022-01-03 | 2022-01-04 | 40,000 | $5.08 | $203.2K | 43,500 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2021-06-14 | 2021-06-16 | 31,347 | — | $0 | 31,347 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2021-06-10 | 2021-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award | 2021-06-10 | 2021-06-14 | 15,000 | — | $0 | 22,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2021-05-17 | 2021-05-17 | 4,186 | $0.89 | $3.7K | 316,292 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | C Conversion deriv | 2021-04-14 | 2021-04-16 | 7,585 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | C Conversion | 2021-04-14 | 2021-04-16 | 75,850 | — | $0 | 320,478 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2021-02-16 | 2021-04-16 | 4,144 | $1.72 | $7.1K | 244,628 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2021-02-16 | 2021-02-17 | 4,144 | $1.72 | $7.1K | 485,756 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2021-02-04 | 2021-02-05 | 600,000 | — | $0 | 600,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2020-12-04 | 2020-12-07 | 29,760 | $0.13 | $3.9K | 29,760 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2020-12-04 | 2020-12-07 | 39,680 | $0.63 | $25.0K | 225,674 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2020-11-16 | 2020-11-18 | 6,094 | $0.52 | $3.2K | 215,994 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2020-08-14 | 2020-08-17 | 4,245 | $0.60 | $2.5K | 222,088 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award | 2020-06-25 | 2020-06-29 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2020-06-03 | 2020-06-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2020-05-15 | 2020-05-18 | 4,426 | $0.63 | $2.8K | 226,333 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2020-02-18 | 2020-02-19 | 4,324 | $0.83 | $3.6K | 230,759 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2020-01-22 | 2020-01-24 | 900,000 | — | $0 | 900,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2020-01-02 | 2020-01-03 | 8,345 | $0.97 | $8.1K | 235,083 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-12-24 | 2019-12-26 | 75,850 | $0.13 | $9.9K | 75,850 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-12-24 | 2019-12-26 | 7,585 | $6.66 | $50.5K | 7,585 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-11-14 | 2019-11-15 | 5,838 | $0.64 | $3.7K | 243,428 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-10-10 | 2019-10-15 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-10-01 | 2019-10-02 | 8,743 | $0.68 | $5.9K | 249,266 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-08-15 | 2019-08-16 | 4,375 | $0.55 | $2.4K | 258,009 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-07-01 | 2019-07-02 | 5,783 | $1.31 | $7.6K | 262,384 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-05-16 | 2019-05-16 | 39,352 | $1.22 | $48.0K | 268,167 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-05-14 | 2019-05-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2019-05-14 | 2019-05-16 | 188,385 | — | $0 | 307,519 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-08 | 33,194 | $0.13 | $4.3K | 33,194 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-05-07 | 2019-05-21 | 33,194 | $0.13 | $4.3K | 33,194 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2019-05-07 | 2019-05-08 | 33,194 | $1.08 | $35.8K | 64,542 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2019-05-07 | 2019-05-21 | 33,194 | $1.08 | $35.8K | 64,542 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-04-01 | 2019-04-03 | 5,842 | $0.98 | $5.7K | 31,348 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-02-05 | 2019-02-06 | 65,000 | — | $0 | 65,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2019-02-05 | 2019-02-06 | 65,000 | $0.95 | $61.8K | 84,148 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2019-01-02 | 2019-07-18 | 1,500 | — | $0 | 1,500 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2018-05-31 | 2018-06-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2018-05-17 | 2018-05-21 | 725,000 | — | $0 | 725,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2018-01-05 | 2018-01-05 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2018-01-02 | 2018-03-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2017-07-25 | 2017-07-25 | 219,780 | $0.91 | $200.0K | 241,297 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2017-05-04 | 2017-05-08 | 750,000 | — | $0 | 750,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2017-02-15 | 2017-02-23 | 160,000 | — | $0 | 160,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2017-01-30 | 2017-02-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2016-11-02 | 2016-11-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2016-10-05 | 2016-10-07 | 59,625 | — | $0 | 59,625 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2016-03-03 | 2016-03-07 | 10,000 | $7.19 | $71.9K | 10,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2016-01-04 | 2016-01-06 | 420,000 | — | $0 | 420,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2015-05-22 | 2015-05-27 | 28,000 | — | $0 | 28,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2015-02-03 | 2015-02-05 | 202,650 | — | $0 | 202,650 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | P Buy | 2014-09-15 | 2014-09-15 | 5,000 | $4.69 | $23.5K | 13,026 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2014-02-07 | 2014-02-11 | 225,000 | — | $0 | 225,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2013-11-29 | 2014-02-11 | 3,980 | $5.34 | $21.3K | 3,980 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2013-07-31 | 2013-08-02 | 12,000 | — | $0 | 764,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2013-07-31 | 2013-08-02 | 12,000 | $7.80 | $93.6K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2013-07-31 | 2013-08-02 | 12,000 | $1.66 | $19.9K | 12,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2013-07-26 | 2013-07-29 | 10,000 | — | $0 | 776,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2013-07-26 | 2013-07-29 | 10,000 | $7.40 | $74.0K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2013-07-26 | 2013-07-29 | 10,000 | $1.66 | $16.6K | 10,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2013-05-28 | 2013-05-30 | 28,000 | — | $0 | 786,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2013-05-28 | 2013-05-30 | 28,000 | $7.00 | $196.0K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2013-05-28 | 2013-05-30 | 28,000 | $1.66 | $46.5K | 28,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2013-02-15 | 2013-02-19 | 310,000 | — | $0 | 310,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2012-07-13 | 2012-07-13 | 30,000 | — | $0 | 814,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-07-13 | 2012-07-13 | 20,000 | $6.70 | $134.0K | 10,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-07-13 | 2012-07-13 | 10,000 | $6.90 | $69.0K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2012-07-13 | 2012-07-13 | 30,000 | $1.66 | $49.8K | 30,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2012-06-29 | 2012-06-29 | 12,000 | — | $0 | 844,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2012-06-29 | 2012-06-29 | 12,000 | $1.66 | $19.9K | 12,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-06-29 | 2012-06-29 | 12,000 | $6.30 | $75.6K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2012-06-28 | 2012-06-29 | 26,000 | — | $0 | 856,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-06-28 | 2012-06-29 | 26,000 | $5.90 | $153.4K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2012-06-28 | 2012-06-29 | 26,000 | $1.66 | $43.2K | 26,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2012-06-27 | 2012-06-29 | 70,000 | — | $0 | 882,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2012-06-27 | 2012-06-29 | 70,000 | $1.66 | $116.2K | 70,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-06-27 | 2012-06-29 | 20,000 | $4.90 | $98.0K | 50,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-06-27 | 2012-06-29 | 20,000 | $5.25 | $105.0K | 30,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-06-27 | 2012-06-29 | 30,000 | $5.50 | $165.0K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2012-01-25 | 2012-01-26 | 350,000 | — | $0 | 350,000 | SEC↗ |